United Kingdom

Participation in EDCTP
projects (2014-2019)
United Kingdom
Type of grants
Allocation of EDCTP funding by institution/organisation
Signed grants
EDCTP member country

All Participating States in the second EDCTP programme (EDCTP2) are members of the EDCTP Association General Assembly (GA), which is EDCTP’s ultimate decision-making body. Each member has an equal voting right in the GA and is represented by nominated delegates from the government ministry and/or its mandated institution(s). EDCTP Association members commit to a minimum contribution of € 200,000 per year (cash, in-kind or a combination) to activities within the scope of the EDCTP2 programme.

Contribution to the EDCTP programme
Participation in EDCTP calls
Research and Innovation Actions (RIAs)
Coordination and Support Actions (CSAs)
Grants by disease/activity
Grants by medical intervention

*Cross-cutting activities not related to a particular intervention.

Representative entity

Medical Research Council
Website

PSIAs included in EDCTP2 annual work plans 2014-2020
Participating States’ Initiated Activities (PSIAs)

Participating States’ Initiated Activities (PSIAs) are the main mechanism for PSs to make in-kind contributions and comprise activities in the scope of EDCTP2 that are funded and implemented independently from EDCTP by one or more PSs. PSIAs count towards the matching of funds by the European Commission (up to a maximum ceiling of € 683 million), provided they are included in the EDCTP2 annual work plans and are co-labelled as being part of the EDCTP2 programme supported by the European Union. PSIAs are important because they provide an overview of activities that the PSs fund on poverty-related diseases, hence promoting research collaboration in Europe and sub-Saharan Africa. 

PSIAs by type of grants
PSIAs by disease

€50.80 M

€5.98 M

€1.89 M

€47.07 M

€5.34 M

€73.50 M

€13.92 M

€82.35 M

€26.67 M

€79.61 M

€7.16 M

€32.94 M

€48.68 M

€28.12 M

€4.88 M

€64.32 M

0

0

About us

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public–public partnership between 14 European and 16 African countries, supported by the European Union. EDCTP’s vision is to reduce the individual, social and economic burden of poverty-related infectious diseases by affecting sub-Saharan Africa. EDCTP’s mission is to accelerate the development of new or improved medicinal products for the identification, treatment and prevention of infectious diseases, including emerging and re-emerging diseases, through pre- and postregistration clinical studies, with emphasis on phase II and III clinical trials. Our approach integrates conduct of research with development of African clinical research capacity and networking. The second EDCTP programme is implemented by the EDCTP Association supported under Horizon 2020, the European Union’s Framework Programme for Research and Innovation.

Contact us

For more information, please contact us or leave a message using this form.
Please enter your name
Please enter a correct e-mail address
Please enter a comment
Thank you! Your message has been sent.
Something went wrong while submitting the form. Try again.

Share this publication

Forward this page by e-mail or share it directly on social media.

Search

Enter a search term to search the EDCTP publications.
Minimal length to search is 3 characters

This publication uses cookies

We use functional and analytical cookies to improve our website. In addition, third parties place tracking cookies to display personalised advertisements on social media. By clicking accept you consent to the placement of these cookies.